• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对103名乙肝表面抗原携带者进行的16至21年随访研究

[A follow-up study on 103 HBsAg carriers during 16-21 years].

作者信息

Hong D Q, Li J S, Dai H M

机构信息

Department of Epidemiology Nanjing Medical University.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 1994 Sep;28(5):287-90.

PMID:7842894
Abstract

One hundred and three HBsAg carriers were followed up for 16-21 years with an average of 18.6 years. Results showed 30 of them recovered from carrier status. 26 became post-hepatitis carriers and 21 asymptomatic carriers, six suffered from acute hepatitis B and seven chronic active hepatitis, and 13 died. Negative conversion rate of HBsAg averaged 33.3% with 13.8% for those aged 30 or less and 42.6% for those over 30. Negative conversion rate of HBsAg and recover rate in carriers with high-titer HBsAg were very significantly lower, and incidence rates of acute hepatitis B and chronic active hepatitis significantly higher than those with low titer.

摘要

103名乙肝表面抗原(HBsAg)携带者接受了16至21年的随访,平均随访时间为18.6年。结果显示,其中30人从携带者状态康复。26人成为肝炎后携带者,21人成为无症状携带者,6人患急性乙型肝炎,7人患慢性活动性肝炎,13人死亡。HBsAg转阴率平均为33.3%,30岁及以下者为13.8%,30岁以上者为42.6%。高滴度HBsAg携带者的HBsAg转阴率和康复率非常显著地低于低滴度携带者,急性乙型肝炎和慢性活动性肝炎的发病率则显著高于低滴度携带者。

相似文献

1
[A follow-up study on 103 HBsAg carriers during 16-21 years].对103名乙肝表面抗原携带者进行的16至21年随访研究
Zhonghua Yu Fang Yi Xue Za Zhi. 1994 Sep;28(5):287-90.
2
[Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].[前瞻性随访队列研究在HBsAg携带者原发性肝癌诊疗中的意义]
Zhonghua Yi Xue Za Zhi. 2001 Jul 25;81(14):856-9.
3
[Long term follow-up of non-symptomatic HBsAg carriers].无症状乙肝表面抗原携带者的长期随访
An Med Interna. 1991 Jun;8(6):269-72.
4
[A follow-up study on HBsAg carriers and factors affecting negative-conversion].[乙肝表面抗原携带者随访研究及影响转阴的因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 1984 Jan;18(1):32-4.
5
[The prevalence of the HBsAg carrier state among pregnant women and its effect on newborn infants. V. A follow-up of the processes of HBsAg clearance in pregnant women discovered as antigen carriers].[孕妇中乙肝表面抗原携带者状态的患病率及其对新生儿的影响。五、对被发现为抗原携带者的孕妇乙肝表面抗原清除过程的随访]
Akush Ginekol (Sofiia). 1993;32(1):14-6.
6
Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.台湾已育女性中的乙型肝炎病毒感染与肝细胞癌:全国性队列研究
J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.
7
Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).慢性乙型肝炎病毒感染的自然史:在希腊北部进行的一项长达12年随访的队列研究(欧洲区域间合作项目I-II/EC的一部分)
J Med Virol. 2005 Oct;77(2):173-9. doi: 10.1002/jmv.20434.
8
Clinicopathologic studies of asymptomatic HBsAg carriers: with special emphasis on carriers older than 40 years.无症状HBsAg携带者的临床病理研究:特别关注40岁以上的携带者。
Hepatogastroenterology. 1987 Dec;34(6):251-4.
9
[106 cases of HBsAg carriers and factors influencing the prognosis: a follow-up study of 7-12 years].106例乙肝表面抗原携带者及其预后影响因素:一项7至12年的随访研究
Zhonghua Liu Xing Bing Xue Za Zhi. 1985 Aug;6(4):223-6.
10
[Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].[慢性乙型肝炎携带者的随访。血清学病程及再激活风险]
Rev Esp Enferm Dig. 1996 May;88(5):335-9.

引用本文的文献

1
Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis.胱抑素 C、COVID-19 严重程度和死亡率:系统评价和荟萃分析。
J Nephrol. 2022 Jan;35(1):59-68. doi: 10.1007/s40620-021-01139-2. Epub 2021 Aug 14.
2
Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.中国山东省儿童乙型肝炎疫苗补种项目的成本效益分析
Hum Vaccin Immunother. 2014;10(10):2983-91. doi: 10.4161/hv.29944.